Daganat teszt
Breast and ovarian cancer
Common genetic diseases
Complex genetic diagnostics
Bundled tests
Request test

We provide answers to your questions about your possibilities.

„Knowledge of your genetic background helps you plan your future.”

Research, development, and service in one hand

We believe in creating the possibility of a healthier and more conscious life by revealing your genetic background

The identification of genetic risk factors can largely influence your future decisions

Personalized oncotherapeutic drugs have more targeted effect against tumours

KRAS and NRAS diagnostics

At present, the most efficient therapy of colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) targets the EGFR signalling pathway by inhibiting its different members. The proteins encoded by the RAS genes are key players in the EGFR signalling pathway, and the presence of activating mutations in them indicates a definite resistance to anti-EGFR therapies. KRAS mutations are the most common among RAS mutations; thus, routine screening of all CRC and NSCLC patients is recommended for this gene. If the KRAS and the NRAS genes are mutation-free, the anti-EGFR therapy can be efficient.

Analysis of the gene is recommended mainly in cases of colorectal cancer (CRC) and non-small cell lung cancer (NSCLC).

Click here for information about ordering our services.